AI is reshaping both scientific innovation and business operations in life sciences
KPMG's extensive research into AI use across eight industries, finds that unlike sectors still experimenting or struggling to scale the tech, life sciences organizations have embedded AI deeply into their operations — from R&D and clinical trials to supply chains and commercial functions. For many, AI is not just a tool, but a core part of how they work.
The challenge is no longer whether AI can deliver value, but how companies can reshape their organizations to fully realize its potential. The Intelligent life sciences report explores how leading life sciences firms are making this transition — adapting their operating models, breaking down silos, and fostering AI-driven agility. This report also offers actionable insights into how organizations can take a value-based approach to AI that helps to accelerate innovation, unlock new growth opportunities, and maximize the impact of their AI investments.